Page 22 - Scientific Program News Today

/PRNewswire/ -- BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative...

/PRNewswire/ -- Novartis today announced updated median overall survival (OS) results for Kisqali® (ribociclib) in combination with fulvestrant in...

Published: Jun 01, 2021 June 1, 2021 11:00 UTC Learnings to be Presented by Carlos Moraes, Ph.D., from University of Miami at UMDF’s Mitochondrial Medicine Symposium on June 4, 2021 Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies with its ARCUS® genome editing platform, today announced a new paper published online in Nature Communications that reports preclinical results using an ARCUS ...

Search jobs 01-Jun-2021  Precision BioSciences Announces New Study Published in Nature Communications Using Engineered ARCUS Nuclease to Target Mutant Mitochondrial DNA In Vivo   Learnings to be Presented by Carlos Moraes, Ph.D., from University of Miami at UMDF’s Mitochondrial Medicine Symposium on June 4, 2021 DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic ...

Share this article Share this article HORSHAM, Pa., May 21, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has granted the accelerated approval of RYBREVANT TM (amivantamab-vmjw) for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose di...

(0) ITM AG, a leading radiopharmaceutical company, today announced that it will host a virtual symposium titled, "New Approaches for Targeted Radionuclide Therapy in Precision Oncology" as an ancillary event in parallel to the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. The symposium will feature renowned key opinion leaders in the field and will be held on Friday, June 4 th, 2021 from 9.30 am 11.00 am ET 3.30 pm 5.00 pm CEST. The interactive live-session will explore ...

Title: A multicenter open-label phase 1 study evaluating the safety and tolerability of HMPL-306 in patients with locally advanced or metastatic solid tumors with IDH mutations. Lead Author Session: Abstract Number: About Savolitinib Savolitinib is an oral, potent, and highly selective small molecule inhibitor of MET, a receptor tyrosine kinase which has been shown to function abnormally in many types of solid tumors promoting tumor growth, angiogenesis, and metastasis. Savolitinib has been stu...

Francesca Belouad, MA, is a Research Psychologist in GEB-SDGE. She is responsible for administrating interviews and overseeing clinical aspects of the NIMH Family Study. Francesca has been employed as a Research Psychologist at the NIMH since 2000, when she was recruited by Dennis Charney, MD, during the formation of the Mood and Anxiety Disorders Research Program. Prior to this, she held research positions at the Section on Development Psychology at the NIMH, Outpatient Psychiatry at the Wash...

Registration Now Open for FIRST, Institute of Food Technologists New Digital Experience España - español Share this article Share this article CHICAGO, April 27, 2021 /PRNewswire/ -- Registration is now open for Food Improved by Research, Science, and Technology (FIRST), a new digital experience powered by the Institute of Food Technologists (IFT). Programming and presentations will take place virtually from July 19-21, 2021 while the Solution Exchange will be offered from July 19-23, 2021. ...

8th Emirates Pathology & Digital Pathology Utilitarian Conference March 5, 2021 Greetings from the Pathology Utilitarian Conference. On the behalf of Utilitarian Committee, we warmly welcome you to the 8th Emirates Pathology & Digital Pathology Utilitarian Conference (EPUCG2021). The motto of the Pathology Conference – 8EPUCG2021: Empowering the sphere of Pathology profession and Pathologists Community for the improved understanding of disease worldwide. We have an exciting and informative pr...